Nothing Special   »   [go: up one dir, main page]

BE851237A - Hydrazinophtalazines substituees - Google Patents

Hydrazinophtalazines substituees

Info

Publication number
BE851237A
BE851237A BE174774A BE174774A BE851237A BE 851237 A BE851237 A BE 851237A BE 174774 A BE174774 A BE 174774A BE 174774 A BE174774 A BE 174774A BE 851237 A BE851237 A BE 851237A
Authority
BE
Belgium
Prior art keywords
hydrazinophtalazines
substituted
substituted hydrazinophtalazines
Prior art date
Application number
BE174774A
Other languages
English (en)
French (fr)
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of BE851237A publication Critical patent/BE851237A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • C07D237/34Phthalazines with nitrogen atoms directly attached to carbon atoms of the nitrogen-containing ring, e.g. hydrazine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • C07D237/32Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BE174774A 1976-02-09 1977-02-09 Hydrazinophtalazines substituees BE851237A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4896/76A GB1567907A (en) 1976-02-09 1976-02-09 (3-amino-2-hydroxypropoxy)-1-hydrazonophthalazines and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
BE851237A true BE851237A (fr) 1977-08-09

Family

ID=9785918

Family Applications (1)

Application Number Title Priority Date Filing Date
BE174774A BE851237A (fr) 1976-02-09 1977-02-09 Hydrazinophtalazines substituees

Country Status (6)

Country Link
US (1) US4093725A (de)
JP (1) JPS5297986A (de)
BE (1) BE851237A (de)
DE (1) DE2705414A1 (de)
FR (1) FR2340310A1 (de)
GB (1) GB1567907A (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4442094A (en) * 1980-12-23 1984-04-10 Merck & Co., Inc. (3-Aralkylamino-2-or-propoxy)heterocyclic compounds
US4331679A (en) * 1980-12-23 1982-05-25 Merck Sharp & Dohme (I.A.) Corp. (3-Aralkylamino-2-or-propoxy) heterocyclic compounds
US4349673A (en) * 1980-12-23 1982-09-14 Merck & Co., Inc. Benzoxazines
US4656168A (en) * 1980-12-23 1987-04-07 Merck & Co., Inc. (3-aralkylamino-2-or-propoxy)heterocyclic compounds in method of effecting bronchodilation
DE4029807A1 (de) * 1990-09-20 1992-03-26 Bayer Ag 4-amino-3-hydroxy-phthalid, sowie ein verfahren zu seiner herstellung
DE4426373A1 (de) * 1994-07-26 1996-02-01 Bayer Ag 3-Substituierte Chinolin-5-carbonsäurederivate und Verfahren zu ihrer Herstellung
WO2004050657A2 (en) * 2002-11-27 2004-06-17 Artesian Therapeutics, Inc. COMPOUNDS WITH MIXED PDE-INHIBITORY AND β-ADRENERGIC ANTAGONIST OR PARTIAL AGONIST ACTIVITY FOR TREATMENT OF HEART FAILURE

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4011321A (en) * 1973-12-19 1977-03-08 Smith Kline & French Laboratories Limited Pharmaceutical compositions and methods of inhibiting β-adrenergic receptors

Also Published As

Publication number Publication date
FR2340310B1 (de) 1980-03-07
GB1567907A (en) 1980-05-21
DE2705414A1 (de) 1977-08-11
FR2340310A1 (fr) 1977-09-02
US4093725A (en) 1978-06-06
JPS5297986A (en) 1977-08-17

Similar Documents

Publication Publication Date Title
ATA204777A (de) Schischu
BE850723A (fr) Phenyl-amidines substituees
DK294577A (da) Koretojssede
AT353866B (de) Hoergeraet
AT349288B (de) Ruehrwerksmuehle
AT359262B (de) Raffstore
DD132036A5 (de) Magnetbandkassettengeraet
ATA505377A (de) Ruehrwerksmuehle
FI772653A (fi) Serveringsfatserie
FI772984A (fi) Olikformig utjaemningskrets
AT378100B (de) Halmerntegeraet
AT346259B (de) Webschaft
AT370310B (de) Elektrokardioskop
BE851237A (fr) Hydrazinophtalazines substituees
AT349360B (de) Unmagnetische tretmine
AT358854B (de) Kruemelwalze
AT356609B (de) Kristallisator
AT346734B (de) Springmine
BE851920A (fr) Phenylguanidines substituees
AT356871B (de) Saegegatter
AT346041B (de) Sheddach
AT371411B (de) Skibob
DK269477A (da) Substituerede hydrocarbyl-thioethylaminer
AT345469B (de) Deodorantien
ATA480076A (de) Kipplager

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SMITH KLINE & FRENCH LABORATORIES LTD

Effective date: 19840209